16-2029661-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000424542.7(NHERF2):c.293G>A(p.Arg98Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000408 in 1,567,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000040 ( 0 hom. )
Consequence
NHERF2
ENST00000424542.7 missense
ENST00000424542.7 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.80
Genes affected
NHERF2 (HGNC:11076): (NHERF family PDZ scaffold protein 2) This gene encodes a member of the NHERF family of PDZ scaffolding proteins. These proteins mediate many cellular processes by binding to and regulating the membrane expression and protein-protein interactions of membrane receptors and transport proteins. The encoded protein plays a role in intestinal sodium absorption by regulating the activity of the sodium/hydrogen exchanger 3, and may also regulate the cystic fibrosis transmembrane regulator (CFTR) ion channel. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.15408748).
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHERF2 | NM_001130012.3 | c.293G>A | p.Arg98Gln | missense_variant | 2/7 | ENST00000424542.7 | NP_001123484.1 | |
NHERF2 | NM_004785.6 | c.293G>A | p.Arg98Gln | missense_variant | 2/7 | NP_004776.3 | ||
NHERF2 | XM_047434923.1 | c.293G>A | p.Arg98Gln | missense_variant | 2/7 | XP_047290879.1 | ||
NHERF2 | XM_047434924.1 | c.-26G>A | 5_prime_UTR_variant | 2/7 | XP_047290880.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHERF2 | ENST00000424542.7 | c.293G>A | p.Arg98Gln | missense_variant | 2/7 | 1 | NM_001130012.3 | ENSP00000408005 | P1 | |
NHERF2 | ENST00000432365.6 | c.293G>A | p.Arg98Gln | missense_variant | 2/7 | 1 | ENSP00000402857 | |||
NHERF2 | ENST00000567504.5 | c.266G>A | p.Arg89Gln | missense_variant | 2/3 | 3 | ENSP00000454361 | |||
NHERF2 | ENST00000563587.5 | c.-26G>A | 5_prime_UTR_variant | 1/6 | 2 | ENSP00000455909 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000287 AC: 5AN: 174468Hom.: 0 AF XY: 0.0000107 AC XY: 1AN XY: 93366
GnomAD3 exomes
AF:
AC:
5
AN:
174468
Hom.:
AF XY:
AC XY:
1
AN XY:
93366
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000396 AC: 56AN: 1414948Hom.: 0 Cov.: 31 AF XY: 0.0000300 AC XY: 21AN XY: 699428
GnomAD4 exome
AF:
AC:
56
AN:
1414948
Hom.:
Cov.:
31
AF XY:
AC XY:
21
AN XY:
699428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74348
GnomAD4 genome
AF:
AC:
8
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | The c.293G>A (p.R98Q) alteration is located in exon 2 (coding exon 2) of the SLC9A3R2 gene. This alteration results from a G to A substitution at nucleotide position 293, causing the arginine (R) at amino acid position 98 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L
MutationTaster
Benign
D;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;T;T
Sift4G
Benign
T;T;T
Polyphen
0.93
.;P;.
Vest4
0.15, 0.26
MVP
MPC
0.069
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at